Browse the corpus

REFERENCES Barradell LB and Fitton A, “Artesunate: A Review of Its Pharmacology and Theurapeutic Efficacy in the Treatment of Malaria,” Drugs , 1995, 50(4):714-41. [PubMed 8536555 ] Calender DM and Hsue G, “Artesunate: Investigational Drug for the Treatment of Severe Falciparum Malaria in Hawai'i,” Hawaii Medical J , 2011, 70(4):77-9. [PubMed 21785506 ] Clark RL, White TE, A Clode S, et al, “Developmental Toxicity of Artesunate and an Artesunate Combination in the Rat and Rabbit,” Birth Defects Res B Dev Reprod Toxicol , 2004, 71(6): 380-94. [PubMed 15617018 ] Clark RL, Brannen KC, Sanders JE, et al, “Artesunate and Artelinic Acid: Association of Embryotoxicity, Reticulocytopenia, and Delayed Stimulation of Hematopoiesis in Pregnant Rats,” Birth Defects Res B Dev Reprod Toxicol , 2011, 92(1) 2011, 92(1):52-68. [PubMed 21312322 ] Davis TM, Phuong HL, Ilett KF, et al, “Pharmacokinetics and Pharmacodynamics of Intravenous Artesunate in Severe Falciparum Malaria,” Antimicrob Agents Chemother , 2001, 45(1):181-6. [PubMed 11120963 ] De Clercq D, Vercruysse J, Vérle P, et al, “Efficacy of artesunate against Schistosoma mansoni infections in Richard Toll, Senegal,” Trans R Soc Trop Med Hyg , 2000, 94 (1):90–1. [PubMed 10748910 ] Dondorp A, Nosten F, Stepniewska K, et al, “Artesunate versus Quinine for Treatment of Severe Falciparum Malaria: A Randomised Trial,” Lancet , 2005, 366(9487):717-25. [PubMed 16125588 ] Franco-Paredes C, Dismukes R, Nicolls D, et al, “Neurotoxicity Due to Antimalarial Therapy Associated With Misdiagnosis of Malaria,” Clin Infect Dis , 2005, 40(11):1710-1. [PubMed 15889385 ] Gasasira AF, Kamya MR, Achan J, et al, “High Risk of Neutropenia in HIV-infected Children Following Treatment With Artesunate Plus Amodiaquine for Uncomplicated Malaria in Uganda,” Clin Infect Dis , 2008, 46(7), 985-91. [PubMed 18444813 ] Hess KM, Goad JA, and Arguin PM, “Intravenous Artesunate for the Treatment of Severe Malaria,” Ann Pharmacother , 2010, 44(7-8):1250-8. [PubMed 20551300 ] Inyang-Etoh PC, Ejezie GC, Useh MF, et al, “Efficacy of Artesunate in the Treatment of Urinary Schistosomiasis, in an Endemic Community in Nigeria,” Ann Trop Med Parasitol , 2004, 98(5):491-9. [PubMed 15257799 ] Leonardi E, Gilvary G, White NJ, et al, “Severe Allergic Reactions to Oral Artesunate: A Report of Two Cases,” Trans R Soc Trop Med Hyg , 2001, 95(22):182-3. [PubMed 11355556 ]

Inyang-Etoh PC, Ejezie GC, Useh MF, et al, “Efficacy of Artesunate in the Treatment of Urinary Schistosomiasis, in an Endemic Community in Nigeria,” Ann Trop Med Parasitol , 2004, 98(5):491-9. [PubMed 15257799 ] Leonardi E, Gilvary G, White NJ, et al, “Severe Allergic Reactions to Oral Artesunate: A Report of Two Cases,” Trans R Soc Trop Med Hyg , 2001, 95(22):182-3. [PubMed 11355556 ] Li Q, Cantilena LR, Leary KH, et al, “Pharmacokinetic Profiles of Artesunate After Single Intravenous Doses at 0.5, 1, 2, 4, and 8 mg/kg in Healthy Volunteers: A Phase I Study,” Am J Trop Med Hyg , 2009, 81(4):615-21. [PubMed 19815876 ] Li Q, Si Y, Smith KS, et al, “Embryotoxicity of Artesunate in Animal Species Related to Drug Tissue Distribution and Toxicokinetic Profiles,” Birth Defects Res B Dev Reprod Toxicol , 2008, 83(4):435-45. [PubMed 18636509 ] McGready R, Cho T, Cho JJ, et al, “Artemisinin Derivatives in the Treatment of Falciparum Malaria in Pregnancy,” Trans R Soc Trop Med Hyg , 1998, 92(4):430–3. [PubMed 9850401 ] McGready R, Cho T, Samuel, et al, “Randomized Comparison of Quinine-Clindamycin versus Artesunate in the Treatment of Falciparum Malaria in Pregnancy,” Trans R Soc Trop Med Hyg , 2001, 95(6):651-6. [PubMed 11816439 ] McGready R, Tan SO, Ashley EA, et al, “A Randomised Controlled Trial of Artemether-Lumefantrine versus Artesunate for Uncomplicated Plasmodium Falciparum Treatment in Pregnancy,” PLoS Med , 2008, 5(12):e253 [PubMed 19265453 ] Miller LG and Panosian CB, “Ataxia and Slurred Speech After Artesunate Treatment for Falciparum Malaria,” N Engl J Med , 1997, 336(18):1328. [PubMed 9132599 ] Newton PN, Barnes KI, Smith PJ, et al, “The Pharmacokinetics of Intravenous Artesunate in Adults With Severe Falciparum Malaria,” Eur J Clin Pharmacol , 2006, 62(12):1003-9. [PubMed 17089111 ] Olliaro P, “Disease and Drug Interactions: Treating Malaria With Artesunate Plus Amodiaquine in Patients Also Receiving Treatment for Concomitant HIV Infection,” Clin Infect Dis , 2008, 46(7):992-3. [PubMed 18444814 ] Onyamboko MA, Meshnick SR, Fleckenstein L, et al, “Pharmacokinetics and Pharmacodynamics of Artesunate and Dihydroartemisinin Following Oral Treatment in Pregnant women With Asymptomatic Plasmodium falciparum Infections in Kinshasa DRC,” Malar J , 2011, 10:49. [PubMed 21352601 ]

Olliaro P, “Disease and Drug Interactions: Treating Malaria With Artesunate Plus Amodiaquine in Patients Also Receiving Treatment for Concomitant HIV Infection,” Clin Infect Dis , 2008, 46(7):992-3. [PubMed 18444814 ] Onyamboko MA, Meshnick SR, Fleckenstein L, et al, “Pharmacokinetics and Pharmacodynamics of Artesunate and Dihydroartemisinin Following Oral Treatment in Pregnant women With Asymptomatic Plasmodium falciparum Infections in Kinshasa DRC,” Malar J , 2011, 10:49. [PubMed 21352601 ] Rosenthal PJ, “Artesunate for the Treatment of Severe Falciparum Malaria,” N Engl J Med , 2008, 358(17):1829–36. [PubMed 18434652 ] Shapira MY, Resnick IB, Chou S, et al, “Artesunate as a Potent Antiviral Agent in a Patient With Late Drug-Resistant Cytomegalovirus Infection After Hematopoietic Stem Cell Transplantation,” Clin Infect Dis , 2008, 46(9):1455-7. [PubMed 18419454 ] Zoller T, Junghanss T, Kapaun A, et al, “Intravenous Artesunate for Severe Malaria in Travelers, Europe,” Emerg Infect Dis , 17(5):771-7. [PubMed 21529383 ] Topic 17088 Version 5.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0604-27.109.116.13-E03BC582ED-S244013.14]